Carmen Elena Gómez | Vaccine | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Carmen Elena Gómez
National Biotechnology Center | CSIC

          Carmen Elena Gómez
Affiliation National Biotechnology Center | CSIC
Country Spain
Scopus ID 35796367700
Documents 291
Citations 10,146
h-index 47
Subject Area Vaccine
Event Global Diseases Research Awards
ORCID 0000-0002-9473-283X

Carmen Elena Gómez is a researcher affiliated with the National Biotechnology Center of the Spanish National Research Council (CSIC), Spain. Her scientific activities focus on vaccine research, biotechnology, and biomedical innovation. The Innovative Research Award recognizes distinguished contributions in developing impactful scientific approaches and advancing research knowledge within the global health landscape. Research profiles and publication records are evaluated through internationally recognized scholarly databases including Scopus.[1]

Abstract

The Innovative Research Award highlights researchers whose scientific achievements contribute to advances in biomedical sciences and healthcare innovation. Carmen Elena Gómez has established a research profile associated with vaccine development and biotechnology, supported by extensive scholarly publications, citation impact, and international scientific recognition. Her work represents contributions toward understanding and improving vaccine technologies for public health applications.[1]

Keywords

Vaccine Research, Biotechnology Innovation, Immunology, Biomedical Research and Scientific Excellence. [2]

Introduction

Vaccines represent a major area of biomedical research aimed at preventing infectious diseases and improving population health outcomes. Researchers working in vaccine science contribute through immunological studies, platform development, translational research, and evaluation of novel strategies. Carmen Elena Gómez’s academic contributions align with these objectives through research activities documented in international scientific databases.[2]

Research Profile

The researcher profile indicates affiliation with the National Biotechnology Center | CSIC in Spain. According to Scopus indexing information, the profile includes 291 documents, 10,146 citations, and an h-index of 47, reflecting a sustained research presence within the scientific literature.[1]

Research Contributions

The research contributions associated with vaccine science include investigations into vaccine platforms, immune responses, and biotechnology-based approaches. Such research supports the broader scientific objective of improving preventive healthcare strategies and strengthening preparedness against infectious diseases.[3]

Publications

The publication record of Carmen Elena Gómez includes peer-reviewed scientific outputs indexed within international research databases. These publications contribute to the understanding of vaccine technologies, molecular biology, and biomedical applications. Selected publications may include DOI-based identification for reliable scholarly access.[4]

Research Impact

Research impact is reflected through citation metrics, publication activity, and contributions to scientific knowledge. The citation count and h-index provide quantitative indicators of academic influence while recognizing that research quality is assessed through broader scholarly evaluation methods.[1]

Award Suitability

The Innovative Research Award acknowledges researchers demonstrating meaningful scientific contributions and advancement of knowledge. Carmen Elena Gómez’s documented research activity in vaccine science, supported by academic publications and measurable research indicators, aligns with the objectives of this recognition category. [2]

Conclusion

Carmen Elena Gómez represents a scientific profile associated with vaccine research and biotechnology innovation. Her academic record, publication activity, and research impact demonstrate continued engagement with internationally recognized biomedical research efforts.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Carmen Elena Gómez, Author ID 35796367700. Scopus.https://www.scopus.com/authid/detail.uri?authorId=35796367700
  2. Global Diseases Research Awards. (2026). Innovative Research Award.
    https://globaldiseases.org/
  3. Delaloye, J., Roger, T., Steiner-Tardivel, Q.-G., Le Roy, D., Knaup Reymond, M., Akira, S., Petrilli, V., Gomez, C. E., Perdiguero, B., Tschopp, J., Pantaleo, G., Esteban, M., & Calandra, T. (2009). Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathogens, 5(6), e1000480.
    https://doi.org/10.1371/journal.ppat.1000480
  4. Gómez, C. E., Perdiguero, B., & Esteban, M. (2021). Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19. Vaccines, 9(3), 243.
    https://doi.org/10.3390/vaccines9030243
  5. Gili, V. F., Carletti, L., Locatelli, A., Rocco, D., Finazzi, M., Ghirardini, L., Favero, I., Gomez, C., Lemaître, A., Celebrano, M., De Angelis, C., & Leo, G. (2016). Monolithic AlGaAs second-harmonic nanoantennas. Optics Express, 24(14), 15965–15975.
    https://doi.org/10.1364/OE.24.015965

Noemí Sevilla | Vaccine Research | Excellence in Research Award

Published on by Global Diseases Research

Prof. Dr. Noemí Sevilla | Vaccine Research | Excellence in Research Award 

Professor | Centro de Investigación en Sanidad Animal (CISA)-CSIC | Spain

Prof. Dr. Noemí Sevilla Hidalgo is a distinguished Full Professor and Director at the Centro de Investigación en Sanidad Animal (CISA-INIA, CSIC, Spain), with a prolific career spanning over three decades in virology, immunology, and animal health, focusing on zoonotic and veterinary pathogens. Her research has elucidated viral immune evasion strategies, host-pathogen interactions, and immune responses in both small and large animal models, directly informing vaccine design. After completing her PhD in Molecular Biology at Universidad Autónoma de Madrid, where she received the Doctorate Extraordinary Award, she pursued postdoctoral training at The Scripps Research Institute (TSRI, USA) under a Human Frontiers Fellowship, studying dendritic cell roles in viral immunity and demonstrating dual viral evasion mechanisms. These results were published in high-impact journals and have received over 3,115 citations. Returning to Spain via the Ramon y Cajal program, she established her research group at CISA, focusing on Bluetongue virus (BTV), Peste des Petits Ruminants virus (PPRV), and more recently, SARS-CoV-2 and Crimean-Congo hemorrhagic fever virus. Her contributions span viral immune evasion, characterization of host immune responses to BTV and PPRV, and the development of recombinant adenoviral vaccine platforms. Sevilla has actively contributed to scientific leadership through conference organization, editorial service, and grant review panels. She has received eight competitive fellowships and authored 70 publications, maintaining an h-index of 30 with 3,115 citations, reflecting her global impact and sustained contributions to virology, immunology, and vaccine research.

Profiles: Scopus | ORCID

Featured Publications

1. Louloudes-Lázaro, A., Nogales-Altozano, P., Rojas, J. M., Veloz, J., Carlón, A. B., Van Rijn, P. A., Martín, V., Fernández-Sesma, A., & Sevilla, N. (2025). Double-stranded RNA orbivirus disrupts the DNA-sensing cGAS-sting axis to prevent type I IFN induction. Cellular and Molecular Life Sciences.

2. Herder, V., Caporale, M., MacLean, O. A., Pintus, D., Huang, X., Nomikou, K., Palmalux, N., Nichols, J., Scivoli, R., Boutell, C., … (2024). Correlates of disease severity in bluetongue as a model of acute arbovirus infection. PLoS Pathogens.

3. Ciudad, C. J., Valiuska, S., Rojas, J. M., Nogales-Altozano, P., Aviñó, A., Eritja, R., Chillón, M., Sevilla, N., & Noé, V. (2024). Polypurine reverse hoogsteen hairpins as a therapeutic tool for SARS-CoV-2 infection. Journal of Biological Chemistry. Cited by: 4

4. Herder, V., Caporale, M., MacLean, O. A., Pintus, D., Huang, X., Nomikou, K., Palmalux, N., Nichols, J., Scivoli, R., Boutell, C., … (2024). A machine learning framework to identify the correlates of disease severity in acute arbovirus infection [Preprint]. bioRxiv.Cited by: 4

5. Pinsino, A., & Sevilla, N. (2024). Editorial: Women in comparative immunology. Frontiers in Immunology.Cited by: 5